A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas

被引：0
|
作者：
Agulnik, Mark
Okuno, Scott H.
Van Tine, Brian Andrew
Pollack, Seth
Weiss, Mia C.
Hirbe, Angela C.
Viveiros, Pedro
Schulte, Brian
Frankel, Paul Henry
Attia, Steven
Siontis, Brittany L.
Milhem, Mohammed M.
Monga, Varun
Charlson, John A.
Robinson, Steven Ian
Yoon, Janet
机构：
[1] City Hope Comprehens Canc Ctr, Durarte, CA USA
[2] Mayo Clin, Rochester, MN USA
[3] Washington Univ St Louis, St Louis, MO USA
[4] Northwestern Univ, Chicago, IL USA
[5] Washington Univ, Sch Med, St Louis, MO USA
[6] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[7] Mayo Clin, Jacksonville, FL USA
[8] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA
[9] Univ Iowa, Iowa City, IA USA
[10] Med Coll Wisconsin, Milwaukee, WI USA
[11] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11505
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] Trabectedin: useful in leiomyosarcoma and liposarcoma, but less so in other soft tissue sarcomas
    Schuetze, S.
    ANNALS OF ONCOLOGY, 2021, 32 (08) : 957 - 958
  • [22] Phase II study of eribulin and pembrolizumab in patients (pts) with metastatic soft tissue sarcomas (STS): Report of LMS cohort.
    Nathenson, Michael
    Choy, Edwin
    Carr, Neena D.
    Hibbard, Hayley D.
    Mazzola, Emanuele
    Catalano, Paul J.
    Thornton, Katherine Anne
    Morgan, Jeffrey A.
    Cote, Gregory Michael
    Merriam, Priscilla
    Wagner, Andrew J.
    Demetri, George D.
    George, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
    Agulnik, Mark
    Mohindra, Nisha Anjali
    Milhem, Mohammed M.
    Attia, Steven
    Robinson, Steven Ian
    Rademaker, Alfred
    Abbinanti, Susan E.
    Cehic, Rasima
    Humphreys, Catherine
    Prudner, Bethany
    Okuno, Scott H.
    Van Tine, Brian Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft tissue sarcomas after failure of anthracycline and ifosfamide
    Yoo, C.
    Ahn, J. H.
    Lee, J.
    Rha, S. Y.
    Park, K. H.
    Kim, T. M.
    Kim, Y. J.
    Lee, H. J.
    Lee, K. H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S888 - S888
  • [25] Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study
    Urakawa, Hiroshi
    Kawai, Akira
    Goto, Takahiro
    Hiraga, Hiroaki
    Ozaki, Toshifumi
    Tsuchiya, Hiroyuki
    Nakayama, Robert
    Naka, Norifumi
    Matsumoto, Yoshihiro
    Kobayashi, Eisuke
    Okuma, Tomotake
    Kunisada, Toshiyuki
    Ando, Masahiko
    Ueda, Takafumi
    Nishida, Yoshihiro
    CANCER SCIENCE, 2020, 111 (09) : 3303 - 3312
  • [26] Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group
    Woll, PJ
    Judson, I
    Lee, SM
    Rodenhuis, S
    Nielsen, OS
    Buesa, JM
    Lorigan, PC
    Leyvraz, S
    Hermans, C
    van Glabbeke, M
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) : 410 - 412
  • [27] Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
    Maki, Robert G.
    D'Adamo, David R.
    Keohan, Mary L.
    Saulle, Michael
    Schuetze, Scott M.
    Undevia, Samir D.
    Livingston, Michael B.
    Cooney, Matthew M.
    Hensley, Martee L.
    Mita, Monica M.
    Takimoto, Chris H.
    Kraft, Andrew S.
    Elias, Anthony D.
    Brockstein, Bruce
    Blachere, Nathalie E.
    Edgar, Mark A.
    Schwartz, Lawrence H.
    Qin, Li-Xuan
    Antonescu, Cristina R.
    Schwartz, Gary K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3133 - 3140
  • [28] A phase II study of intravenous reolysin (wild-type reovirus) in the treatment of patients with bone and soft tissue sarcomas metastatic to the lung
    Soefje, S. A.
    Sarantopoulos, J.
    Sankhala, K. K.
    Mita, A. C.
    Mahany, J. J., Jr.
    Carmona, T.
    Coffey, M.
    Gill, G. M.
    Mettinger, K.
    Mita, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide
    Changhoon Yoo
    Jeeyun Lee
    Sun Young Rha
    Kyong Hwa Park
    Tae Min Kim
    Yu Jung Kim
    Hyo Jin Lee
    Kyung Hee Lee
    Jin-Hee Ahn
    Investigational New Drugs, 2013, 31 : 1602 - 1608
  • [30] Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide
    Yoo, Changhoon
    Lee, Jeeyun
    Rha, Sun Young
    Park, Kyong Hwa
    Kim, Tae Min
    Kim, Yu Jung
    Lee, Hyo Jin
    Lee, Kyung Hee
    Ahn, Jin-Hee
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1602 - 1608
12345